Clinical trial
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally…
NCT00134095 · Fukushima Medical University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00134095 |
|---|---|
| Title | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer |
| Official title | Phase II Clinical Study of Preoperative S-1/CPT-11 Combination Chemotherapy in Patients With Locally Advanced Gastric Cancer |
| Lead sponsor | Fukushima Medical University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Procedure |
| Interventions | irinotecan hydrochloride, tegafur-gimeracil-oteracil potassium, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 70 |
| Start date | Sep 1, 2004 |
| Primary completion | Aug 1, 2008 |
| First posted | Aug 24, 2005 |
| Last update posted | Sep 17, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: